Skip to main content
    T

    Twist Bioscience Corp (TWST)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $112.00
    +6.96 (+6.63%)

    Market Cap: $6.96B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Twist Bioscience Corp (TWST) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Twist Bioscience (TWST) has a market cap of $6.96B and an enterprise value of $6.43B. It kept -28.34% of revenue as net income over the last 12 months. Revenue grew 22.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 7.67% below the market cap, as cash exceeds debt.

    Market Cap$6.96B
    Enterprise Value$6.43B
    Latest price (Nov 17, 2026)$112.00

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 1.14% in the quarter ended Jun 30, 2026 and grew 3.60% a year over 2 years.

    Shares Outstanding62.62M
    Shares Change (YoY)+4.01%
    Shares Change (QoQ)+1.14%
    Share Count Growth (2Y CAGR)+3.60%

    Valuation Ratios

    Sales and book value multiples are 15.3x and 7.9x. Its year-end P/S ranged from 4.9x to 59.8x from 2018 to 2025.

    P/S Ratio15.3x
    Forward P/S12.5x
    P/B Ratio7.9x
    P/TBV Ratio9.1x

    Valuation history and multiples

    Price Statistics

    The stock is up 316.82% over 52 weeks and trades 25.09% below its 50-day average.

    Beta (1Y)2.87
    52-Week Change+316.82%
    1-Month Change-19.87%
    3-Month Change-21.34%
    6-Month Change+126.26%
    5-Year Change+28.60%
    Total Return (1Y)+316.82%
    Total Return (3Y CAGR)+67.07%
    Total Return (5Y CAGR)-0.03%
    Return vs SPY (1Y)+319.21%
    Max Drawdown (1Y)-48.76%
    Max Drawdown (3Y)-58.97%
    Sharpe Ratio (1Y)1.76
    Correlation with SPY (1Y)0.47
    50-Day Average$149.51
    200-Day Average$93.88
    52-Week Range$25.23 to $219.71
    RSI (14 Days)39.6
    Average Volume (20 Days)2.48M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.86x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.86x
    Quick Ratio5.49x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -14.66% over the last 12 months, against a 5-year average of -27.13%.

    Return on Equity (ROE)-14.66%
    Return on Assets (ROA)-11.61%
    ROE (5Y Average)-27.13%
    ROA (5Y Average)-21.34%
    ROIC (5Y Average)-27.19%
    Asset Turnover0.52x
    Inventory Turnover5.36x
    Receivables Turnover6.79x
    Cash Conversion Cycle87 days

    Scores

    TWST has an Altman Z-Score of 16.84, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score16.84
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $459.43M over the last 12 months.

    Revenue$459.43M
    Revenue Growth (YoY)+22.00%
    Gross Profit$240.80M
    Operating Income-$139.46M
    Pretax Income-$129.80M
    Net Income-$130.20M
    EBITDA-$112.12M
    Reported EPS (TTM)-$1.98

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 79.29% of the $1.12B in total assets.

    Cash and Equivalents$533.99M
    Total Debt$0
    Net Cash$533.99M
    Net Cash Per Share$8.53
    Working Capital$611.41M
    Shareholder Equity$888.02M
    Book Value Per Share$14.18
    Tangible Book Value$771.66M
    Tangible Book Per Share$12.32
    Total Assets$1.12B
    Total Liabilities$233.79M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $47.58M of capital spending, operating cash flow left -$89.01M of free cash flow.

    Operating Cash Flow-$41.43M
    Capital Expenditures$47.58M
    Free Cash Flow-$89.01M
    FCF Per Share-$1.34
    Depreciation and Amortization$26.48M
    Share Repurchases$42.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -30.35%, against a 5-year average of -68.21%.

    Gross Margin52.41%
    Operating Margin-30.35%
    Pretax Margin-28.25%
    Net Margin-28.34%
    EBITDA Margin-24.40%
    FCF Margin-19.37%
    Gross Margin (5Y Average)44.75%
    Operating Margin (5Y Average)-68.21%
    Net Margin (5Y Average)-61.23%

    Growth

    Revenue grew 23.30% a year over 3 years.

    Revenue Growth (3Y CAGR)+23.30%
    Revenue Growth (5Y CAGR)+28.27%
    Book Value Per Share Growth (2Y CAGR)-15.20%
    Tangible Book Per Share Growth (2Y CAGR)-13.96%

    Revenue and profit by year

    Dividends and Yields

    TWST does not pay a dividend. Its free cash flow yield is -1.27%.

    FCF Yield-1.27%
    Buyback Yield-6.31%
    Shareholder Yield-6.31%

    Peer Position

    Against 8 similar companies, TWST has the 5th highest P/S.

    P/S Ratio15.3x vs 15.5x median
    Revenue Growth (Trailing 4 Quarters, YoY)+22.00% vs +27.75% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 19.75% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+19.75%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TWST

    What is TWST's market cap?

    Twist Bioscience has a market cap of $6.96B. Its enterprise value, which adds debt and subtracts cash, is $6.43B.

    How many shares of TWST are outstanding?

    Twist Bioscience has 62.62M shares outstanding. The count is up 4.01% from a year earlier.

    Does TWST pay a dividend?

    No. Twist Bioscience does not pay a dividend.

    How much debt does TWST have?

    Twist Bioscience has $0 of total debt and $533.99M of cash and equivalents, a net cash position of $533.99M.